Parametric Portfolio Associates’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.97M | Buy |
151,111
+12,664
| +9% | +$309K | ﹤0.01% | 2016 |
|
|
2021
Q4 | $3.29M | Sell |
138,447
-14,450
| -9% | -$357K | ﹤0.01% | 2135 |
|
|
2021
Q3 | $3.83M | Buy |
152,897
+14,242
| +10% | +$363K | ﹤0.01% | 2017 |
|
|
2021
Q2 | $3.6M | Buy |
138,655
+11,537
| +9% | +$314K | ﹤0.01% | 2081 |
|
|
2021
Q1 | $3.25M | Buy |
127,118
+686
| +0.5% | +$17.6K | ﹤0.01% | 2460 |
|
|
2020
Q4 | $2.53M | Buy |
126,432
+30,064
| +31% | +$589K | ﹤0.01% | 2512 |
|
|
2020
Q3 | $1.65M | Buy |
96,368
+23,003
| +31% | +$435K | ﹤0.01% | 2627 |
|
|
2020
Q2 | $1.6M | Sell |
73,365
-7,939
| -10% | -$182K | ﹤0.01% | 2638 |
|
|
2020
Q1 | $1.88M | Sell |
81,304
-18,036
| -18% | -$524K | ﹤0.01% | 2421 |
|
|
2019
Q4 | $3.28M | Sell |
99,340
-3,483
| -3% | -$112K | ﹤0.01% | 2356 |
|
|
2019
Q3 | $3.27M | Buy |
102,823
+12,032
| +13% | +$351K | ﹤0.01% | 2329 |
|
|
2019
Q2 | $2.33M | Buy |
90,791
+30,629
| +51% | +$780K | ﹤0.01% | 2569 |
|
|
2019
Q1 | $1.53M | Sell |
60,162
-3,551
| -6% | -$106K | ﹤0.01% | 2806 |
|
|
2018
Q4 | $2.17M | Buy |
63,713
+4,606
| +8% | +$150K | ﹤0.01% | 2533 |
|
|
2018
Q3 | $2.11M | Sell |
59,107
-13,480
| -19% | -$476K | ﹤0.01% | 2681 |
|
|
2018
Q2 | $2.5M | Sell |
72,587
-1,766
| -2% | -$61.9K | ﹤0.01% | 2535 |
|
|
2018
Q1 | $2.5M | Sell |
74,353
-10,678
| -13% | -$338K | ﹤0.01% | 2464 |
|
|
2017
Q4 | $3.25M | Buy |
85,031
+9,161
| +12% | +$366K | ﹤0.01% | 2249 |
|
|
2017
Q3 | $2.85M | Buy |
75,870
+13,521
| +22% | +$477K | ﹤0.01% | 2323 |
|
|
2017
Q2 | $2.33M | Buy |
62,349
+915
| +1% | +$33.1K | ﹤0.01% | 2418 |
|
|
2017
Q1 | $2.41M | Buy |
61,434
+6,214
| +11% | +$233K | ﹤0.01% | 2321 |
|
|
2016
Q4 | $1.92M | Sell |
55,220
-15,970
| -22% | -$627K | ﹤0.01% | 2387 |
|
|
2016
Q3 | $2.8M | Sell |
71,190
-6,953
| -9% | -$277K | ﹤0.01% | 2095 |
|
|
2016
Q2 | $2.95M | Sell |
78,143
-72,382
| -48% | -$2.42M | ﹤0.01% | 2017 |
|
|
2016
Q1 | $5.79M | Buy |
150,525
+61,111
| +68% | +$2.28M | 0.01% | 1422 |
|
|
2015
Q4 | $4.3M | Buy |
89,414
+9,135
| +11% | +$423K | 0.01% | 1512 |
|
|
2015
Q3 | $3.17M | Sell |
80,279
-6,343
| -7% | -$270K | 0.01% | 1488 |
|
|
2015
Q2 | $3.69M | Sell |
86,622
-9,947
| -10% | -$396K | 0.01% | 1658 |
|
|
2015
Q1 | $3.81M | Sell |
96,569
-5,424
| -5% | -$200K | 0.01% | 1602 |
|
|
2014
Q4 | $3.68M | Sell |
101,993
-20,775
| -17% | -$698K | 0.01% | 1560 |
|
|
2014
Q3 | $3.62M | Buy |
122,768
+35,735
| +41% | +$986K | 0.01% | 1490 |
|
|
2014
Q2 | $2.19M | Buy |
87,033
+328
| +0.4% | +$8.11K | ﹤0.01% | 1989 |
|
|
2014
Q1 | $2.24M | Buy |
86,705
+14,450
| +20% | +$364K | 0.01% | 1937 |
|
|
2013
Q4 | $1.63M | Buy |
72,255
+3,630
| +5% | +$70.1K | ﹤0.01% | 2231 |
|
|
2013
Q3 | $973K | Buy |
68,625
+16,043
| +31% | +$215K | ﹤0.01% | 2598 |
|
|
2013
Q2 | $718K | Buy |
+52,582
| New | +$716K | ﹤0.01% | 2694 |
|
Other funds holding NTUS
N
Parametric Portfolio Associates's NTUS Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Natus Medical Inc (NTUS) stake by 9.1% in Q1 2022, buying an estimated $309K and bringing the position to 151,111 shares worth $3.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2016.
Parametric Portfolio Associates first reported a position in NTUS in Q2 2013 and has held it in 36 quarters since. The position peaked at $5.79M in Q1 2016. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.
- Parametric Portfolio Associates held 151,111 shares of Natus Medical Inc worth $3.97M as of Q1 2022.
- Parametric Portfolio Associates bought 12,664 Natus Medical Inc shares in Q1 2022, an estimated $309K.
- Natus Medical Inc made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2016 holding.
- Parametric Portfolio Associates first reported a position in Natus Medical Inc in Q2 2013 and has held it in 36 quarters since.
- Parametric Portfolio Associates's Natus Medical Inc position peaked at $5.79M in Q1 2016.
- 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.